Skip to contentE
Envoy Medical, Inc.
E
COCHEnvoy Medical, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$75.00K$75.00Kderived+78.6% vs Q4 2024 Net Income-$6.59M-$6.59MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$6,385,000N/M Operating Cash Flowderived-$5,685,000N/M Free Cash Flowderived-$5,857,000N/M Margins · derivedOperating margin-8513.3%+2315.2 pt vs Q4 2024
Net margin-8781.3%+2213.9 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 23, 2026 · 82 d after period end